CervoMed (CRVO) Other Accumulated Expenses (2009 - 2026)
CervoMed (CRVO) reported Other Accumulated Expenses of $2.08 million for Q1 2025, up 47.8% from $1.41 million a year earlier but down 12.1% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2024, CervoMed posted Other Accumulated Expenses of $2.37 million, up 22.5% from FY2023.
- Other Accumulated Expenses has a five-year compound annual growth rate of 45.9% (FY2019 to FY2024).
- By year, Other Accumulated Expenses came in at $1.93 million in FY2023 (+200.1%), $644,252 in FY2022 (-67.5%), $1.98 million in FY2021 (+11.5%) and $1.78 million in FY2020 (+395.5%).
- Five-year quarterly Other Accumulated Expenses spans a low of $317,075 in Q2 2020 and a high of $2.37 million in Q4 2024.
- Year over year, Other Accumulated Expenses has now increased in each of the last six quarters, with growth averaging 47.4% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q4 2020 (growth of 395.5%); the low point was Q2 2023 (a decline of 68.1%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $2.37 million (Q4 2024), $2.16 million (Q3 2024) and $1.09 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | CervoMed | 20.73 Mn | -57.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.36 Bn |
| Jun 30, 2026 | 2.35 Bn |
| Mar 31, 2026 | 2.22 Bn |
| Dec 31, 2025 | 3.20 Bn |
| Sep 30, 2025 | 3.25 Bn |
| Jun 30, 2025 | 2.80 Bn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 532,550.00 |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 644,252.00 |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.98 Mn |
API Access
CervoMed Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();